Recruiting Atrial Fibrillation Studies in Newark
About Atrial Fibrillation Clinical Trials in Newark
Atrial fibrillation (AFib) is the most common type of heart arrhythmia, causing an irregular and often rapid heartbeat. It significantly increases the risk of stroke, heart failure, and other complications. Treatment includes blood thinners, heart rate or rhythm control medications, and procedures like ablation.
There are currently 1 atrial fibrillation clinical trials recruiting participants in Newark, OH. These studies are seeking a combined 2,300 participants. Research is being sponsored by University of Pennsylvania. Clinical trial participation is free and participants receive study-related medical care at no cost.
Atrial Fibrillation Clinical Trials in Newark — FAQ
Are there atrial fibrillation clinical trials in Newark?
Yes, there are 1 atrial fibrillation clinical trials currently recruiting in Newark, OH. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Newark?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Newark research site will contact you about next steps.
Are clinical trials in Newark free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Newark studies also compensate for your time and travel.
What atrial fibrillation treatments are being tested?
The 1 active trials in Newark are testing new therapies including novel drugs, biologics, and treatment approaches for atrial fibrillation.
Data updated July 13, 2026 from ClinicalTrials.gov